Octreotide in the treatment of severe chemotherapy-induced diarrhea
Open Access
- 1 February 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (2) , 227-230
- https://doi.org/10.1023/a:1008372228462
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Recommended guidelines for the treatment of chemotherapy-induced diarrhea.Journal of Clinical Oncology, 1998
- Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.Journal of Clinical Oncology, 1996
- Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.Journal of Clinical Oncology, 1995
- Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinomaCancer, 1993
- Morphometric analysis of the effects of antineoplastic drugs on mucosa of normal ileum and ileal anastomoses in ratsExperimental and Molecular Pathology, 1992
- Control of chemotherapy-induced diarrhoea with octreotide in patients receiving 5-fluorouracilEuropean Journal Of Cancer, 1992
- Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancerCancer, 1989
- Effect of the Somatostatin Analogue Sandostatin (SMS 201–995) on Gastrointestinal, Pancreatic and Biliary Function and Hormone Release in Normal MenDigestion, 1987
- Drug Therapy for Diarrheal Diseases: A Look AheadClinical Infectious Diseases, 1986
- Necrotizing colitis in patients with cancerThe American Journal of Medicine, 1979